Precision BioSciences Inc. (NASDAQ: DTIL)
$10.31
+0.0650 ( +0.64% ) 59.2K
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Market Data
Open
$10.31
Previous close
$10.24
Volume
59.2K
Market cap
$71.89M
Day range
$10.05 - $10.39
52 week range
$8.25 - $21.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
4 | Insider transactions | 1 | Apr 22, 2024 |
8-k | 8K-related | 13 | Apr 16, 2024 |
8-k | 8K-related | 13 | Mar 27, 2024 |
10-k | Annual reports | 105 | Mar 27, 2024 |
8-k | 8K-related | 20 | Mar 01, 2024 |
8-k | 8K-related | 13 | Feb 13, 2024 |